Holen Sie sich die Stockscreener-App
2.37
1.71%
0.03
Schlusskurs vom Vortag:
$2.34
Offen:
$2.32
24-Stunden-Volumen:
121.40K
Relative Volume:
0.61
Marktkapitalisierung:
$21.23M
Einnahmen:
$93.76M
Nettoeinkommen (Verlust:
$-13.68M
KGV:
-0.9011
EPS:
-2.63
Netto-Cashflow:
$8.77M
1W Leistung:
+0.85%
1M Leistung:
+0.85%
6M Leistung:
+138.00%
1J Leistung:
+5.31%
1-Tages-Spanne:
$2.26
$2.41
1-Wochen-Bereich:
$2.25
$2.59
52-Wochen-Spanne:
$0.95
$2.82
Aytu Biopharma Inc Stock (AYTU) Company Profile
Firmenname
Aytu Biopharma Inc
Sektor
Telefon
(720) 437-6580
Adresse
7900 E. UNION AVENUE, DENVER
Vergleichen Sie AYTU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AYTU
Aytu Biopharma Inc
|
2.365 | 23.19M | 93.76M | -13.68M | 8.77M | -2.63 |
|
ZTS
Zoetis Inc
|
143.28 | 63.05B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.79 | 43.33B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.165 | 40.43B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.11 | 22.97B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
434.04 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-01 | Eingeleitet | Lake Street | Buy |
| 2025-06-30 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2021-03-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-05-29 | Eingeleitet | H.C. Wainwright | Buy |
Aytu Biopharma Inc Aktie (AYTU) Neueste Nachrichten
Aytu BioPharma : Corporate Presentation October 2025 View Presentation - MarketScreener
How institutional ownership impacts Aytu BioPharma Inc. stockStop Loss & Proven Capital Preservation Tips - newser.com
Will Aytu BioPharma Inc. stock attract more institutional investors2025 Price Action Summary & Step-by-Step Swing Trade Plans - newser.com
Best data tools to analyze Aytu BioPharma Inc. stockWeekly Trade Analysis & Free Risk Controlled Daily Trade Plans - newser.com
Will Aytu BioPharma Inc. stock see insider buyingQuarterly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com
New Strong Sell Stocks for Oct. 13th - Yahoo Finance
What earnings revisions data tells us about Aytu BioPharma Inc.2025 Key Highlights & Precise Buy Zone Tips - newser.com
Using data models to predict Aytu BioPharma Inc. stock movementMarket Weekly Review & Low Volatility Stock Suggestions - newser.com
Aytu BioPharma to Present at Upcoming October 2025 Conferences - ACCESS Newswire
Oct 22-23: Aytu BioPharma to Present at Maxim Growth Summit and Planet MicroCap Showcase - Stock Titan
How to use Fibonacci retracement on Aytu BioPharma Inc.Analyst Upgrade & Community Supported Trade Ideas - newser.com
Why institutional investors increase stakes in Aytu BioPharma Inc. (AY20) stockAnalyst Upgrade & Verified Swing Trading Watchlists - newser.com
Aytu BioPharma Inc AY20 Stock Analysis and ForecastMomentum Trading Signals & Free Double Digit Growth Tips - earlytimes.in
What analysts say about Aytu BioPharma Inc stockTake Profit Strategies & Fast Profit Trading Tips - earlytimes.in
Is Aytu BioPharma Inc. (AY20) stock attractive for growth fundsJuly 2025 Levels & Risk Adjusted Swing Trade Ideas - newser.com
Can Aytu BioPharma Inc. (AY20) stock withstand sector downturnsEarnings Growth Report & Entry Point Strategy Guides - newser.com
Aytu BioPharma Reports Fiscal 2025 Earnings and EXXUA Launch Plans - MSN
Will Rising Interest Rates Hurt Lupin Limited’s Profit MarginsMarket Correction Analysis & Set Up Real-Time Alerts – It’s Free - earlytimes.in
Aytu BioPharma Inc. stock momentum explainedJuly 2025 Snapshot & High Accuracy Trade Alerts - newser.com
Applying sector rotation models to Aytu BioPharma Inc.Market Performance Report & Technical Pattern Recognition Alerts - newser.com
Aytu outlines EXXUA launch targeting $22B MDD market while streamlining ADHD portfolio - MSN
Is It Time to Lock in Profits on Mefcom Capital Markets Limited StockValue Stock Picks & Minimal Investment Capital Gains - earlytimes.in
What drives Aytu BioPharma Inc AY20 stock priceInterest Rate Changes & Minimal Risk High Reward - earlytimes.in
Aytu BioPharma at Lytham Partners: Strategic Realignment and Growth By Investing.com - Investing.com Canada
Finanzdaten der Aytu Biopharma Inc-Aktie (AYTU)
Umsatz
Nettogewinn
Free Cashflow
ENV
Aytu Biopharma Inc-Aktie (AYTU) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Disbrow Joshua R. | Chief Executive Officer |
Jun 09 '25 |
Buy |
1.50 |
66,666 |
99,999 |
153,257 |
| Disbrow Joshua R. | Chief Executive Officer |
Feb 28 '25 |
Buy |
1.30 |
15,000 |
19,500 |
86,591 |
0.95%
2.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):